KETANSERIN IN COMBINATION WITH BETA-ADRENERGIC-RECEPTOR BLOCKING-AGENTS IN THE TREATMENT OF ESSENTIAL-HYPERTENSION

被引：25

作者：

HEDNER, T ^{[1
]}

PERSSON, B ^{[1
]}

机构：

[1] SAHLGRENS HOSP,DEPT MED 1,HYPERTENS UNIT,S-41345 GOTHENBURG,SWEDEN

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 18卷 / 05期

关键词：

D O I：

10.1111/j.1365-2125.1984.tb02540.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：765 / 771

页数：7

共 18 条

[1]

ANDREN L, 1983, ACTA MED SCAND, V214, P125

[2]

DAVIES OL, 1949, STATISTICAL METHODS

[3] THE ANTIHYPERTENSIVE EFFECTS OF A PURE AND SELECTIVE SEROTONIN-RECEPTOR BLOCKING-AGENT (R 41 468) IN ELDERLY PATIENTS [J].

DECREE, J ;

LEEMPOELS, J ;

DECOCK, W ;

GEUKENS, H ;

VERHAEGEN, H .

ANGIOLOGY, 1981, 32 (02) :137-144

[4]

DEMOULIN JC, 1981, LANCET, V1, P1186

[5] MECHANISM OF THE HYPOTENSIVE EFFECT OF KETANSERIN [J].

FOZARD, JR .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (05) :829-838

[6] KETANSERIN, A NOVEL 5-HYDROXYTRYPTAMINE ANTAGONIST - MONOTHERAPY IN ESSENTIAL-HYPERTENSION [J].

HEDNER, T ;

PERSSON, B ;

BERGLUND, G .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) :121-125

[7] EXPERIENCE WITH KETANSERIN, A SEROTONIN (S2) ANTAGONIST, IN LONGTERM TREATMENT OF ESSENTIAL-HYPERTENSION [J].

HEDNER, T ;

PERSSON, B ;

BERGLUND, G .

CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1984, 6 (03) :743-751

[8]

KALKMAN HO, 1982, J PHARMACOL EXP THER, V222, P227

[9] RECEPTOR-BINDING PROFILE OF R-41-468, A NOVEL ANTAGONIST AT 5-HT2 RECEPTORS [J].

LEYSEN, JE ;

AWOUTERS, F ;

KENNIS, L ;

LADURON, PM ;

VANDENBERK, J ;

JANSSEN, PAJ .

LIFE SCIENCES, 1981, 28 (09) :1015-1022

[10] INDIRECT BLOOD-PRESSURE AND HEART-RATE MEASURED QUICKLY WITHOUT OBSERVER BIAS USING A SEMIAUTOMATIC MACHINE (AUTO-MANOMETER) - RESPONSE TO ISOMETRIC-EXERCISE IN NORMAL HEALTHY MALES AND ITS MODIFICATION BY BETA-ADRENOCEPTOR BLOCKADE [J].

NYBERG, G .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (03) :275-281

← 1 2 →